Phase II study of combination therapy with docetaxel, cisplatin, and S-1 (DCS) for advanced gastric cancer: (KDOG 0601)

被引:0
|
作者
Nakayama, N.
Koizumi, W.
Sasaki, T.
Tanabe, S.
Nishimura, K.
Higuchi, K.
Takagi, S.
Katada, C.
Azuma, M.
Saigenji, K.
机构
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan
[2] Kitasato Univ, East Hosp, Sagamihara, Kanagawa 228, Japan
[3] Kitasato Univ Hosp, Sagamihara, Kanagawa, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4555
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    T Takayama
    Y Sato
    T Sagawa
    T Okamoto
    H Nagashima
    Y Takahashi
    H Ohnuma
    G Kuroiwa
    K Miyanishi
    R Takimoto
    T Matsunaga
    J Kato
    K Yamaguchi
    K Hirata
    Y Niitsu
    British Journal of Cancer, 2007, 97 : 851 - 856
  • [42] Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
    W Koizumi
    S Tanabe
    K Saigenji
    A Ohtsu
    N Boku
    F Nagashima
    K Shirao
    Y Matsumura
    M Gotoh
    British Journal of Cancer, 2003, 89 : 2207 - 2212
  • [43] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Takayama, T.
    Sato, Y.
    Sagawa, T.
    Okamoto, T.
    Nagashima, H.
    Takahashi, Y.
    Ohnuma, H.
    Kuroiwa, G.
    Miyanishi, K.
    Takimoto, R.
    Matsunaga, T.
    Kato, J.
    Yamaguchi, K.
    Hirata, K.
    Niitsu, Y.
    BRITISH JOURNAL OF CANCER, 2007, 97 (07) : 851 - 856
  • [44] Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
    Koizumi, W
    Tanabe, S
    Saigenji, K
    Ohtsu, A
    Boku, N
    Nagashima, F
    Shirao, K
    Matsumura, Y
    Gotoh, M
    BRITISH JOURNAL OF CANCER, 2003, 89 (12) : 2207 - 2212
  • [45] Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer
    Hyeong Su Kim
    Min-Hee Ryu
    Dae Young Zang
    Baek-Yeol Ryoo
    Dae Hyun Yang
    Ji Woong Cho
    Man Sup Lim
    Min-Jeong Kim
    Boram Han
    Dae Ro Choi
    Jung Han Kim
    Joo Young Jung
    Hunho Song
    Choong Kee Park
    Yoon-Koo Kang
    Gastric Cancer, 2016, 19 : 579 - 585
  • [46] Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer
    Kim, Hyeong Su
    Ryu, Min-Hee
    Zang, Dae Young
    Ryoo, Baek-Yeol
    Yang, Dae Hyun
    Cho, Ji Woong
    Lim, Man Sup
    Kim, Min-Jeong
    Han, Boram
    Choi, Dae Ro
    Kim, Jung Han
    Jung, Joo Young
    Song, Hunho
    Park, Choong Kee
    Kang, Yoon-Koo
    GASTRIC CANCER, 2016, 19 (02) : 579 - 585
  • [47] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Noriyuki Hirahara
    Takeshi Matsubara
    Shunsuke Kaji
    Tetsu Yamamoto
    Ryoji Hyakudomi
    Kiyoe Takai
    Kazunari Ishitobi
    Yuki Uchida
    Yoshitsugu Tajima
    BMC Cancer, 21
  • [48] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Hirahara, Noriyuki
    Matsubara, Takeshi
    Kaji, Shunsuke
    Yamamoto, Tetsu
    Hyakudomi, Ryoji
    Takai, Kiyoe
    Ishitobi, Kazunari
    Uchida, Yuki
    Tajima, Yoshitsugu
    BMC CANCER, 2021, 21 (01)
  • [49] Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination
    Kunitoshi Shigeyasu
    Shunsuke Kagawa
    Futoshi Uno
    Masahiko Nishizaki
    Hiroyuki Kishimoto
    Akira Gochi
    Toshikazu Kimura
    Takaomi Takahata
    Yasuyuki Nonaka
    Motoki Ninomiya
    Toshiyoshi Fujiwara
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 937 - 943
  • [50] Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination
    Shigeyasu, Kunitoshi
    Kagawa, Shunsuke
    Uno, Futoshi
    Nishizaki, Masahiko
    Kishimoto, Hiroyuki
    Gochi, Akira
    Kimura, Toshikazu
    Takahata, Takaomi
    Nonaka, Yasuyuki
    Ninomiya, Motoki
    Fujiwara, Toshiyoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 937 - 943